Carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa are a global threat to antimicrobial resistance and may be causative pathogens in cUTI. Cefepime-taniborbactam ...
LAKE FOREST, Ill., June 22 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced it has ...
Zerbaxa is noninferior to meropenem for the treatment of adult patients with ventilated nosocomial pneumonia, or VNP, according to phase 3 data from the ASPECT-NP trial presented at the European ...
In a study, IV fosfomycin appeared less effective than IV ceftriaxone or meropenem for bacteremic UTI caused by multidrug-resistant E. coli, but the drug may be considered for selected patients with ...
Patients were randomized to receive cefiderocol intravenously (IV) every 8 hours (n=145) or meropenem IV every 8 hours (n=146) for a period of 7-14 days, in addition to linezolid (to cover methicillin ...
International Approvals: Glumetza, 500-mg Invirase, Proxinium Canada has approved a once-daily, extended-release formulation of metformin HCl (Glumetza); Europe has approved a 500-mg tablet ...
New Bevacizumab Label Includes Risk for Ovarian Failure The product's package insert now instructs clinicians to inform females of reproductive potential about the risk for ovarian failure with this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback